Diclofenac Epolamine System
Product Images NDC 85766-265

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Diclofenac Epolamine (NDC 85766-265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Diclofenac 01)

Chemical structure diagram showing the molecular formulas of Diclofenac and Epolamine. Diclofenac's structure includes a dichlorophenyl group and a carboxylate moiety, while the Epolamine structure is depicted as 2-(pyrrolidin-1-yl)ethanol with relevant atomic bonds and groups labeled.*

FDA Label Image

Figure 1 (Diclofenac 02)

A line graph comparing the percent of patients improved for Diclofenac Patch versus placebo. The x-axis represents percent improvement from baseline, ranging from 10 to 100 percent, and the y-axis indicates the percent of patients improved, ranging from 0 to 100 percent. The graph shows higher improvement percentages for patients using the Diclofenac Patch relative to placebo across the range.*

FDA Label Image

Figure 2 (Diclofenac 03)

A line graph comparing the percent of patients improved versus percent improvement from baseline for Diclofenac Patch and placebo. The graph shows two lines: one with solid circles for Diclofenac Patch and one with open squares for placebo, depicting patient improvement over a range from 10 to 100 percent improvement from baseline.*

FDA Label Image

Figure 3 (Diclofenac 04)

A line graph comparing the percent of patients improved versus percent improvement from baseline for Diclofenac Patch and placebo. The graph shows two curves, with the Diclofenac Patch consistently demonstrating higher patient improvement rates compared to placebo across increasing levels of improvement.*

FDA Label Image

Figure 4 (Diclofenac 05)

A line graph comparing percent improvement from baseline on the x-axis with percent of patients improved on the y-axis for Diclofenac Patch versus Placebo. The graph shows that a higher percentage of patients improved with Diclofenac Patch compared to Placebo as the percent improvement increased.*

FDA Label Image

1 (Label)

Two product labels for Diclofenac Epolamine Topical System 1.3% relabeled for Sportpharm. One label is for NDC 85766-265-30 with a quantity of 30 topical systems, and the other for NDC 85766-265-15 with a quantity of 15 topical systems. Both labels include distributor Yaral Pharma, Inc., packaging and storage instructions, and cautionary statements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.